{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:32:59Z","timestamp":1737955979685,"version":"3.33.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,26]]},"DOI":"10.7759\/cureus.78002","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T14:35:25Z","timestamp":1737902125000},"source":"Crossref","is-referenced-by-count":0,"title":["Polymyositis-Like Myopathy With Anti-PL-12 Antibody Positivity and Coexisting Antiphospholipid Syndrome: Diagnostic and Management Challenges in the Absence of Systemic Features"],"prefix":"10.7759","author":[{"given":"Andres D","family":"Parga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Raheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg IE","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016, 280:39-51. 10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12936","article-title":"Anti-synthetase syndrome-related interstitial lung disease with anti-PL-12 antibodies","volume":"13","author":"Elferjani B","year":"2021","unstructured":"Elferjani B, Liaqat A, Zaman M, Sexton M. Anti-synthetase syndrome-related interstitial lung disease with anti-PL-12 antibodies. Cureus. 2021, 13:e12936. 10.7759\/cureus.12936","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051084","article-title":"Idiopathic inflammatory myopathies: a review of the classification and impact of pathogenesis","volume":"18","author":"Mandel DE","year":"2017","unstructured":"Mandel DE, Malemud CJ, Askari AD. Idiopathic inflammatory myopathies: a review of the classification and impact of pathogenesis. Int J Mol Sci. 2017, 18:1084. 10.3390\/ijms18051084","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead052","article-title":"The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders","volume":"62","author":"Milisenda JC","year":"2023","unstructured":"Milisenda JC, Pinal-Fernandez I, Lloyd TE, Grau-Junyent JM, Christopher-Stine L, Corse AM, Mammen AL. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders. Rheumatology (Oxford). 2023, 62:3156-60. 10.1093\/rheumatology\/kead052","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X11415306","article-title":"Diagnosis and treatment of the idiopathic inflammatory myopathies","volume":"3","author":"Gazeley DJ","year":"2011","unstructured":"Gazeley DJ, Cronin ME. Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther Adv Musculoskelet Dis. 2011, 3:315-24. 10.1177\/1759720X11415306","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5414\/NP301077","article-title":"Idiopathic inflammatory myopathies overlapping with systemic diseases","volume":"37","author":"Lepreux S","year":"2018","unstructured":"Lepreux S, Hainfellner JA, Vital A. Idiopathic inflammatory myopathies overlapping with systemic diseases. Clin Neuropathol. 2018, 37:6-15. 10.5414\/NP301077","journal-title":"Clin Neuropathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.04.001","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie MM","year":"2014","unstructured":"Dimachkie MM, Barohn RJ. Inclusion body myositis. Neurol Clin. 2014, 32:629-46, vii. 10.1016\/j.ncl.2014.04.001","journal-title":"Neurol Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-21","article-title":"Aberrant repair and fibrosis development in skeletal muscle","volume":"1","author":"Mann CJ","year":"2011","unstructured":"Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Mu\u00f1oz-C\u00e1noves P. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle. 2011, 1:21. 10.1186\/2044-5040-1-21","journal-title":"Skelet Muscle"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone M","year":"2017","unstructured":"Milone M. Diagnosis and management of immune-mediated myopathies. Mayo Clin Proc. 2017, 92:826-37. 10.1016\/j.mayocp.2016.12.025","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00073","article-title":"Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases","volume":"4","author":"Argyropoulos CP","year":"2017","unstructured":"Argyropoulos CP, Chen SS, Ng YH, Roumelioti ME, Shaffi K, Singh PP, Tzamaloukas AH. Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med (Lausanne). 2017, 4:73. 10.3389\/fmed.2017.00073","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier K","year":"2018","unstructured":"Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, Servettaz A. Autoantibodies associated with connective tissue diseases: what meaning for clinicians?. Front Immunol. 2018, 9:541. 10.3389\/fimmu.2018.00541","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd A","year":"2017","unstructured":"Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017, 17:322-8. 10.7861\/clinmedicine.17-4-322","journal-title":"Clin Med (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai K","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, et al.. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol. 2018, 75:1528-37. 10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-3328","article-title":"A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach","volume":"13","author":"Sawal N","year":"2021","unstructured":"Sawal N, Mukhopadhyay S, Rayancha S, Moore A, Garcha P, Kumar A, Kaul V. A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach. J Thorac Dis. 2021, 13:5556-71. 10.21037\/jtd-20-3328","journal-title":"J Thorac Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2023.11.007","article-title":"Early detection of interstitial lung disease in rheumatic diseases: a joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society","author":"Morais A","year":"2023","unstructured":"Morais A, Duarte AC, Fernandes MO, et al.. Early detection of interstitial lung disease in rheumatic diseases: a joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society. Pulmonology. 2023, 10.1016\/j.pulmoe.2023.11.007","journal-title":"Pulmonology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866087","article-title":"Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond","volume":"13","author":"Galindo-Feria AS","year":"2022","unstructured":"Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B. Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond. Front Immunol. 2022, 13:866087. 10.3389\/fimmu.2022.866087","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328689-polymyositis-like-myopathy-with-anti-pl-12-antibody-positivity-and-coexisting-antiphospholipid-syndrome-diagnostic-and-management-challenges-in-the-absence-of-systemic-features","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T14:35:27Z","timestamp":1737902127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328689-polymyositis-like-myopathy-with-anti-pl-12-antibody-positivity-and-coexisting-antiphospholipid-syndrome-diagnostic-and-management-challenges-in-the-absence-of-systemic-features"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.78002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,26]]}}}